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Abstract Photon correlation spectroscopy demonstrated for the 
first time that co-purified meningococcal TbpA+B form a 
complex in solution. This tructure bound hTf and the resultant 
species underwent partial dissociation after exposure to addi- 
tional hTf or following prolonged incubation. Purified TbpA and 
TbpB had similar apparent sizes but showed distinctive size 
profiles suggesting that TbpA forms a largely homogeneous 
population while TbpB may produce more variable particle sizes 
under these conditions. 
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ically their diffusion coefficient (Dr). This, in turn, can be 
inversely related to their size or hydrodynamic sphere equiv- 
alent radius (rh) via the Stokes-Einstein equation: 
D~ - K~T/6~qr~ 
KB is the Boltzmann constant, T the temperature and q the 
solvent viscosity. 
The characteristic time-scale of intensity fluctuation is ex- 
tracted from the detector signal by autocorrelation, which 
generates an exponential curve, the rate of decay of which 
allows the determination of mean Dr. Through detailed anal- 
ysis of its multi-exponentiality, a particle size distribution can 
be constructed representing the species in solution [9,10]. 
1. Introduction 2. Materials and methods 
All species of pathogenic Neisseria express two structurally 
distinct transferrin binding proteins now known as TbpA (100 
kDa) and TbpB (65-85 kDa dependant on strain) [1]. Both 
proteins specifically bind human serum transferrin (hTf, 80 
kDa) and while TbpA and TbpB bind hTf independently 
both are essential for optimal iron uptake from this source 
[2-5]. The suggested structural distinctiveness of TbpA and 
TbpB, coupled with their co-expression, shared ligand specif- 
icity and mutual contribution to bacterial virulence suggests 
that these proteins act in tandem, together fo ming the func- 
tional hTf receptor [6-8]. Despite the convincing and growing 
body of indirect evidence suggesting this association, as yet 
there has been no direct demonstration of a TbpA+B com- 
plex. We have used photon correlation spectroscopy (PCS) to 
characterise TbpA+B, co-purified from Neisseria meningitidis 
and consequently offer novel direct demonstration that these 
proteins interact in vitro. 
Photon correlation spectroscopy is a particle sizing tech- 
nique in which light from a continuous, visible laser beam is 
directed through an ensemble of macromolecules or particles 
in suspension and moving under Brownian motion. Some of 
the coherent laser light is scattered by these particles and is 
collected by a lens, typically set at 90 ° to the incident beam. 
This reflected light is then detected by a photon counting 
photomultiplier (PMT) which generates a digitised signal pro- 
portional to the intensity of the detected light. As the particles 
move relative to each other, the light hey collectively scatter 
changes in phase, and therefore in intensity at a rate propor- 
tional to the speed at which the particles are moving, specif- 
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2.1. Bacterial strains and growth conditions 
Group B N. meningitidis strains SD [11] and B16B6 were inoculated 
onto agar plates containing 5% (v/v) horse blood and grown overnight 
at 37°C in an atmosphere of 5% CO~. Colonies from these plates were 
used to inoculate 100 ml of Mueller Hinton broth (MHB) in a 250 ml 
conical flask which was incubated with shaking at 37°C for 6 h. 5 ml 
of this culture was introduced into 750 ml MHB in 2 1 conical flasks, 
made iron-limited by the addition of ethylendiamine-N,N-diacetic 
acid. (EDDA, 28 ~tM), and incubated with shaking at 37°C for 18 h. 
2.2. Co-purification of TbpA+B 
These proteins were solubilised from iron-limited N~ meningitidis 
whole cells using Elugent detergent (Calbiochem) and hTf Sepharose 
affinity chromatography [12]. Extracts were prepared from strains SD 
and BI6B6 which express high and low molecular mass forms of 
TbpB (85 kDa and 65 kDa respectively). Separate. functionally ctive 
TbpA and TbpB were prepared by chromatofocusing according to the 
published method [13]. The purity of TbpA+B in each preparation 
was assessed by SDS-PAGE [14] and hTf binding capacity was con- 
firmed by dot blotting, probed using hTf horse-radish peroxidase 
conjugate (hTf-HRP). 
2.3. hTf extraction 
A crude protein extract was prepared by ammonium sulphate pre- 
cipitation of human serum, hTf was purified by gel filtration using a 
Superose 12 HR column (Pharmacia Biotechnology) and subsequent 
ion-exchange chromatography involving a Q Sepharose FF HiLoad 
16110 column (Pharmacia Biotechnology) on FPLC. The purity and 
iron binding capacity of the final protein extract were determined by 
SDS-PAGE and electrophoresis in the presence of 6 M urea [15]. hTf 
treated in this way was used in the affinity purification of TbpA+B 
described earlier. 
2.4. Photon correlation spectroscopy 
300 gl samples of co-purified TbpA+B, individual TbpA, TbpB and 
iron free (apo) hTf were prepared in phosphate buffered saline (PBS) 
pH 7.4+2"/o (v/v) Elugent. A solution of apo hTf was also prepared in 
PBS. All solutions contained approx. 500 gg/ml protein as determined 
All rights reserved. 
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by spectrophotometric analysis using a GENEQUANT micro-spec- 
trophotometer (Pharmacia Biotechnology). Samples were passed 
through a 0.2 /am filter prior to analysis in order to remove any 
dust, bacteria or other particulate matter from the solution. Samples 
were then placed in 1 cm light path cuvettes which were allowed to 
equilibrate at 25°C for 10 min in the index matching water bath with- 
in the PCS instrument (Malvern Instruments 4700c~ PCS system in- 
corporating a variable angle light scattering spectrometer/goniometer). 
Each sample was then analysed using a monochromatic, vertically 
polarised laser beam at 488 nm (Spectra-Physics 3 W Argon Ion 
Laser, Model 2020 operated under constant power mode). The 
PMT detector was set at 90 ° to the incident beam and light collected 
through a 100 ktm aperture to define a suitable coherence area. The 
laser intensity (typically 300 mW) was adjusted for each sample type 
such that the mean count rate detected was close to the optimum of 
150 kcounts/s. Sample times were selected automatically by the PCS 
instrument manufacturer's proprietary software (Automeasure Pro- 
gramme Ver 4.0, Malvern Instruments Ltd.). PCS measurements 
were automatically averaged from 10 separate data accumulation pe- 
riods, each with a duration of 60 s. Data sets whose figures indicated 
the transitory presence of dust of other contaminating material (iden- 
tified by excessively long time-scale correlation functions under the 
instrument setting described) were automatically rejected from the 
averaging process. From the data thus collected (a multi-exponential 
correlation function) a particle size distribution could be estimated 
using the Malvern Instruments Ltd. Proprietary deconvolution pro- 
gramme based on the method of cumulants (for full details of cumu- 
lants analysis see [10]). Because lightscattering data is biased towards 
larger particles (intensity of light scattering varying with particle 
volume2), results are expressed as intensity weighted particle size dis- 
tributions. 
To ensure consistency of results the above analyses were carried out 
in triplicate. Standard deviations and mean values were calculated 
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Fig. 2. A: PCS analysis of TbpA+B/hTf complex sizes at variable 
concentrations of hTf. B: Comparison of TbpA+B/hTf complex for- 
mation using co-purified (c) and recombined (r) TbpA+B. 
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Fig. 1. A: Analysis of purified TbpA, TbpB and co-purified (c) 
TbpA+B by PCS. B: PCS analysis of co-purified (c) TbpA+B and 
recombined (r) TbpA and TbpB (1:1 molecular atio). 
3. Results 
Results obtained from blank solutions containing only fil- 
tered PBS+2% (v/v) Elugent showed no characteristic particle 
size peaks even under laser intensities ignificantly higher than 
those used in the analysis of samples containing added protein 
(data not shown). While PCS does not require calibration, 
correct operation of the instrument was confirmed using 500 
nm polystyrene microsphere standards (data not shown). 
All protein samples were analysed under the same solvent 
conditions and because the experiment was designed only to 
determine comparative changes in molecular size and size dis- 
tributions of the added protein, values for solvent Ri and 
viscosity (~) were assumed to be those of water. Given this 
internal consistency adjustments for the presence of solvent 
constituents uch as detergent were unnecessary. In addition, 
previous analyses (these authors unpublished observations) 
have established that Elugent, used at the concentration de- 
scribed above does not prevent hTf binding by TbpA, TbpB 
or TbpA+B. 
Particle size distributions were produced for individual 
TbpA and TbpB solutions, co-purified TbpA+B and separate 
Tbps recombined in an approx. 1:1 molecular ratio. Each 
sample was prepared in PBS+2% (v/v) Elugent in order to 
prevent protein precipitation, hTf was introduced to samples 
of co-purified TbpA+B, individual TbpA and TbpB and re- 
combined Tbps, initially in an approx. 1:1 molecular ratio. 
On those occasions where complex formation could be dem- 
onstrated, the hTf/Tbp molecular atio was increased to 2:1 in 
order to determine whether this effected the ultimate complex 
size. The hTf-Tbp binding event was also monitored over 
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Fig. 3. Time course analysis of TbpA+B/hTf complex formation. 
time, by analysing a sample of hTf and co-purified TbpA+B 
mixed with an approx. 1:1 molecular atio. Data were col- 
lected at 5 min intervals over a period of 35 rain. 
Preliminary analyses were carried out using hTf in the iron 
free (apo) and iron saturated (holo) form. Under these con- 
ditions variable iron saturation was found to have no detect- 
able effect on apparent particle size or on the formation of 
Tbp-hTf complexes. Furthermore, PCS failed to demonstrate 
heterogeneity in the molecular weight of TbpB expressed by 
meningococcal strains SD and B16B6. Consequently, the re- 
maining analyses were carried out using apo hTf and Tbps 
purified from N. meningitidis train B16B6. 
Purified TbpA and TbpB each had an apparent particle 
size of 9.5- 11.5 nm under these conditions (Fig. 1A). The 
trace produced by TbpA had a pronounced peak while 
TbpB produced a much broader profile of particle sizes. Co- 
purified TbpA+B exhibited an apparent size range of 11.5- 
30.1 nm reaching a maximum value at 16.9-20.5 nm. This 
indicated the presence of a species absent from, and signifi- 
cantly larger than those found in either sample of purified 
TbpA or TbpB. Recombination of TbpA and TbpB in a 
1:1 molecular atio produced a trace with a broad range of 
particle sizes similar to that shown by TbpB. The large peak, 
present in co-purified TbpA+B could not be demonstrated in 
this sample (Fig. 1B). 
The addition of hTf to solutions of purified TbpA and 
TbpB produced no evidence of complex formation under 
these conditions, although both proteins bound hTf on dot 
blotting, in ELISA based studies (these authors, unpublished 
data) and in analyses using surface plasmon resonance bio- 
sensors (Bouton et al., in preparation). The addition of hTf to 
co-purified TbpA+B in a 1 : 1 molecular ratio produced a trace 
with one peak at 12.0-14.6 nm, and a second, larger peak 
indicating a predominant particle size of 31.4-38.1 nm (Fig. 
2A). The minor peak spanned a range of values typical of hTf 
while the second was significantly larger than either TbpA, 
TbpB, hTf or co-purified TbpA+B. Increasing the concentra- 
tion of hTf to a 2:1 molecular atio consistently reduced the
apparent size of this complex by approx. 10 nm but had no 
significant effect on the position or magnitude of the minor 
peak. Further increasing the level of hTf in the reaction mix- 
ture had no additional effect on the larger peak (data not 
shown) and the introduction of hTf to TbpA and TbpB, re- 
combined in a 1:1 molecular ratio produced no evidence of 
complex formation (Fig. 2B). 
Examining the Tbp-hTf binding event over time indicated 
the initial presence of a reflecting species of 9.5 11.5 nm (Fig. 
3A). Subsequent analysis howed the progressive development 
of a large peak at 36.343.9 nm accompanied by a reduction 
in the original peak size (Fig. 3B). As the reaction proceeded 
there was a pronounced and consistent down-shift in the 
newly formed, large peak producing a final apparent complex 
size of 24.7-29.8 nm (Fig. 3C). No further changes in peak 
profile were noted after the 35 min experimental period. 
Throughout these analyses standard deviations from the 
mean value represented in each particle size category were 
consistently below 10%. As a consequence of this minimal 
variation and the large number of experimental replicates 
(30) these data have been omitted from all figures. 
4. Discussion 
The results of these analyses provide the first direct demon- 
stration that co-purified meningococcal TbpA and TbpB as- 
sociate in solution, forming a complex larger than either in- 
dividual component. This complex bound hTf under these 
conditions, again producing a structure larger than purified 
TbpA, TbpB, co-purified TbpA+B or hTf. The addition of 
further hTf resulted in a consistent diminution in the size of 
this complex although the resultant species remained larger 
than any of the individual reactant proteins. This pronounced 
down-shift in apparent size inferred that the initial TbpA+B 
complex underwent partial dissociation in solution and the 
consistency of this change suggests the presence of a specific 
dissociation event. Consequently, we suggest hat co-purified 
TbpA+B binds up to two molecules of hTf, consistent with 
the meningococcal hTf receptor being formed from two pro- 
teins each capable of independent ligand interaction. At high- 
er concentrations of hTf, both accessible binding sites may be 
occupied, possibly resulting in stearic interference between the 
bound ligands causing dissociation of the receptor complex. 
Time course analysis of TbpA+B/hTf binding clearly demon- 
strated the progressive formation of a single large complex, 
accompanied by a reduction of intensity in the initial smaller 
species. The larger, putative TbpA+B/hTf complex also 
412 I.C Boulton et al./FEBS Letters 414 (1997) 409~413 
underwent a similar down-shift in size following prolonged 
incubation with hTf, again inferring partial dissociation and 
consistent with previous observations. 
Individual purified TbpA and TbpB had very similar pre- 
dominant particle sizes but showed distinctive analytical pro- 
files, possibly resulting from the suggested structural differ- 
ences between these proteins [16,17]. The broad spectrum of 
sizes apparent in TbpB analysis, coupled with the absence of
any significant peak may suggest hat this protein forms a 
heterogeneous population in solution. It is implied that in 
vivo TbpB is anchored in the meningococcal outer membrane 
by lipid moieties and these may contribute to the inherent 
adhesiveness of this protein, possibly favouring non-specific 
aggregation [5]. The size profile produced by purified TbpA 
was dominated by a single peak, indicating that this protein 
forms a largely homogeneous light scattering population in 
solution. The predicted structure of TbpA suggests that it 
may be an integral membrane, porin-like molecule composed 
largely of anti-parallel [3 strands joined by loops exposed at 
the cell surface and in the periplasm [18]. Although PCS data 
are subject to the limitations discussed below, analysis of 
TbpA by this method confirms that this protein has sufficient 
size to span the lipid bilayer consistent with the proposed 
model [19]. 
Purified TbpA and TbpB, recombined in an approx. 1:1 
molecular atio did not demonstrate complex formation, ei- 
ther in the presence or absence of hTf. However, the func- 
tional activity of these proteins is not in question, having been 
confirmed using a variety of techniques in both the solid and 
fluid phase and in the presence of Elugent (Boulton et al., 
unpublished observations). In contrast with PCS, one interac- 
tant, either hTf, TbpA or TbpB was immobilised in each of 
these previous analyses. In this study the failure of TbpA or 
TbpB to reform the TbpA+B complex or to bind hTf (irre- 
spective of iron saturation) suggests that the presence of both 
reactant species entirely free in solution and in the defined 
physical conditions may prevent he association hTf and in- 
dividual Tbps. However the similarity between traces pro- 
duced by purified TbpB and recombined TbpA+B may 
equally indicate that the 1:1 ratio of TbpA to TbpB used in 
this study contained an excess of TbpB in comparison with 
co-purified TbpA+B. Consequently, we speculate that co-pu- 
rified TbpA+B may contain more TbpA than TbpB. 
While in the presence of detergent, essential in these anal- 
yses, proteins in solution may be incorporated into micelles. It 
is possible that the presence of TbpA and TbpB within such 
inclusions could influence their capacity to bind hTf and to 
reform the TbpA+B complex. In addition, this effect could 
also influence the hydrodynamic radius of molecules in solu- 
tion with clear implications for the apparent particle size as 
determined by PCS. However, as Elugent was included at the 
same concentration i  each solution and failed to produce any 
reflective signal when analysed independently we propose that 
possible micelle formation had a minimal impact on our data. 
Altering the concentration or nature of this detergent, or in- 
deed changing other physical conditions would undoubtedly 
influence apparent particle size and possibly effect the forma- 
tion of protein complexes. However, the consistency of deter- 
gent concentration, pH, osmolarity and temperature within 
this experimental system validates our comparative analyses 
and we make no claims concerning the absolute particle sizes 
indicated by our data. 
PCS is a favourable method for the analysis of proteina- 
ceous solutions, as samples remain in the fluid phase with no 
requirement for either chemical or radio labelling. Data may 
also be collected in real time and sample consumption is rel- 
atively low [20]. However, while PCS is an accurate technique 
for determining the diffusion coefficient of such samples and is 
useful in establishing comparative changes in samples follow- 
ing protein aggregation or disassociation, several assumptions 
must be employed. In extrapolating Dt data through to pro- 
tein size (hydrodynamic radius) or, in particular, to molecular 
weight the Stokes-Einstein approximation assumes a hard 
sphere model and while proteins are neither necessarily 
'hard' (insensitive to nearest neighbour proteins), or true 
spheres, many proteins can be considered sufficiently globular 
(exhibiting an aspect ratio significantly smaller than 3) and 
freely diffusing for the Stokes-Einstein relationship to be val- 
id. Furthermore, protein conformation and structure is so 
variable that estimations of molecular weight from Dt or pro- 
tein size data, can be difficult to accurately predict without 
substantial a priori knowledge of the protein [21]. Accord- 
ingly, data in this paper restrict themselves to comparative 
measurements of estimated protein size and we avoid specu- 
lation on the molecular weight of the TbpA+B complex. De- 
spite these limitations, PCS is an ideal technique for the de- 
tection of complex formation in this size region as the 
intensity of light scattering (Is) varies directly with particle 
size (rh 6) [22]. Clearly then, PCS is acutely sensitive to com- 
plex formation in solution and, subject to appropriate inter- 
pretation of data, constitutes a valuable tool in analyses of 
this type. 
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